carisoprodol

Generic: carisoprodol

Labeler: oxford pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name carisoprodol
Generic Name carisoprodol
Labeler oxford pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

carisoprodol 350 mg/1

Manufacturer
Oxford Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 69584-111
Product ID 69584-111_c2798091-3c51-4962-b72d-f11592ec00f5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040188
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2020-01-20

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69584111
Hyphenated Format 69584-111

Supplemental Identifiers

RxCUI
197446
UNII
21925K482H
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name carisoprodol (source: ndc)
Generic Name carisoprodol (source: ndc)
Application Number ANDA040188 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 350 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (69584-111-10)
  • 500 TABLET in 1 BOTTLE (69584-111-50)
  • 1000 TABLET in 1 BOTTLE (69584-111-90)
source: ndc

Packages (3)

Ingredients (1)

carisoprodol (350 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c2798091-3c51-4962-b72d-f11592ec00f5", "openfda": {"nui": ["N0000175730", "N0000175737"], "unii": ["21925K482H"], "rxcui": ["197446"], "spl_set_id": ["03c3455f-e217-4a7e-908f-609333dc35fc"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Oxford Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69584-111-10)", "package_ndc": "69584-111-10", "marketing_start_date": "20200120"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69584-111-50)", "package_ndc": "69584-111-50", "marketing_start_date": "20200120"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69584-111-90)", "package_ndc": "69584-111-90", "marketing_start_date": "20200120"}], "brand_name": "Carisoprodol", "product_id": "69584-111_c2798091-3c51-4962-b72d-f11592ec00f5", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "69584-111", "dea_schedule": "CIV", "generic_name": "Carisoprodol", "labeler_name": "Oxford Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carisoprodol", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "350 mg/1"}], "application_number": "ANDA040188", "marketing_category": "ANDA", "marketing_start_date": "20200120", "listing_expiration_date": "20261231"}